{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-086655","form_type":"8-K/A","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.589261+00:00","generated_at":"2026-05-30T17:26:32.939075+00:00","sec_items":["3.01","3.02","3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Onconetix resolves Nasdaq delisting risk via reverse split & listing approval","bullets":["Received delisting notice on Sep 18 for bid price & equity non-compliance; Nasdaq approved initial listing on Sep 19, rendering issues moot.","Effected 1-for-40 reverse stock split effective Sep 24; no fractional shares issued.","Converted all Series A Preferred (142,749 shares) and Series B Preferred (6,741,820 shares) into common stock.","Issued 513,424 units to Altos Venture with warrants; all warrants exercised for additional 154,027 shares.","Post-split shares outstanding ~8.3M; common stock continues trading on Nasdaq under ONCO."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-086655","json":"https://secwatch.observer/filing/0001213900-24-086655.json","markdown":"https://secwatch.observer/filing/0001213900-24-086655.md","text":"https://secwatch.observer/filing/0001213900-24-086655.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024086655/0001213900-24-086655-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024086655/ea0217249-8ka1_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:26:32.939075+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a4ff2a5ca1cd8fc5c2a212d5deafa09866181f16","claim":"Onconetix, Inc.: Amended Certificate of Incorporation to effect a 1-for-40 reverse stock split of common stock (effective 2024-09-24).","evidence_excerpt":"On September 23, 2024, the Company filed an amendment (the “ Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation to effect a Reverse Stock Split of all of the outstanding shares of its issued and outstanding Common Stock at a ratio of one-for-forty (1:40). The Reverse Stock Split became effective in accordance with the terms of the Amendment at 12:01 a.m. Eastern Time on September 24, 2024 (the “ Effective Time ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024086655/0001213900-24-086655-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-09-24"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}